MAPK3 and neoplasm: Furthermore, it was demonstrated that fraxetin treatment resulted in a reduction in the expression of p-ERK1/2 in MCF-7 cells, indicating that fraxetin may exert an anti-tumor effect through the MAPK/ERK1/2 signaling pathway (Huo et al., 2013).